{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:41:08Z","timestamp":1787002868513,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-026-01158-1","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:05:38Z","timestamp":1780679138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medicaid coverage for fixed-dose combination antihypertensive medications \u2013 fifty states and Washington, D.C., 2022"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7306-0280","authenticated-orcid":false,"given":"Nicole L.","family":"Therrien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary K.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrice","family":"Lampley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor E.","family":"Streeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-8971","authenticated-orcid":false,"given":"Janet S.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"1158_CR1","unstructured":"US Department of Health and Human Services. The Surgeon General\u2019s call to action to control hypertension. Washington, DC: US Department of Health and Human Services, Office of the Surgeon General; 2020. https:\/\/www.hhs.gov\/sites\/default\/files\/call-to-action-to-control-hypertension.pdf"},{"key":"1158_CR2","unstructured":"Centers for Disease Control and Prevention. Figure 1: Hypertension cascade: hypertension prevalence, treatment, and control estimates among US adults aged 18 years and older applying the criteria from the American College of Cardiology and American Heart Association\u2019s 2017 hypertension guideline\u2014NHANES 2017\u20132020. 2023. https:\/\/millionhearts.hhs.gov\/data-reports\/hypertension-prevalence.html. Accessed January 9, 2026."},{"key":"1158_CR3","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.5888\/pcd15.170362","volume":"15","author":"R Ahuja","year":"2018","unstructured":"Ahuja R, Ayala C, Tong X, Wall HK, Fang J. Public awareness of health-related risks from uncontrolled hypertension. Prev Chronic Dis. 2018;15:E40.","journal-title":"Prev Chronic Dis"},{"key":"1158_CR4","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1377\/hlthaff.2016.0158","volume":"35","author":"TS Purnell","year":"2016","unstructured":"Purnell TS, Calhoun EA, Golden SH, Halladay JR, Krok-Schoen JL, Appelhans BM, et al. Achieving health equity: closing the gaps in health care disparities, interventions, and research. Health Aff. 2016;35:1410\u20135.","journal-title":"Health Aff"},{"key":"1158_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009971","volume":"7","author":"BM Egan","year":"2018","unstructured":"Egan BM. Defining hypertension by blood pressure 130\/80 mm Hg leads to an impressive burden of hypertension in young and middle-aged Black adults: follow-up in the CARDIA study. J Am Heart Assoc. 2018;7:e009971.","journal-title":"J Am Heart Assoc"},{"key":"1158_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ajh\/hpac011","volume":"35","author":"DK Hayes","year":"2022","unstructured":"Hayes DK, Jackson SL, Li Y, Wozniak G, Tsipas S, Hong Y, et al. Blood pressure control among non-Hispanic Black adults is lower than non-Hispanic White adults despite similar treatment with antihypertensive medication: NHANES 2013-2018. Am J Hypertens. 2022;35:514\u201325.","journal-title":"Am J Hypertens"},{"key":"1158_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12170-015-0446-5","volume":"9","author":"PC Balfour Jr","year":"2015","unstructured":"Balfour PC Jr, Rodriguez CJ, Ferdinand KC. The role of hypertension in race-ethnic disparities in cardiovascular disease. Curr Cardiovasc Risk Rep. 2015;9:18.","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"1158_CR8","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103\u201316.","journal-title":"N Engl J Med"},{"key":"1158_CR9","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13\u2013e115.","journal-title":"Hypertension"},{"key":"1158_CR10","first-page":"e114","volume":"152","author":"Writing","year":"2025","unstructured":"Writing, Committee M, Jones DW, Ferdinand KC, Taler SJ, Johnson HM, et al. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;152:e114\u2013e218.","journal-title":"Circulation"},{"key":"1158_CR11","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"MR Law","year":"2009","unstructured":"Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.","journal-title":"BMJ"},{"key":"1158_CR12","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","volume":"326","author":"MR Law","year":"2003","unstructured":"Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427.","journal-title":"BMJ"},{"key":"1158_CR13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1161\/HYPERTENSIONAHA.119.14360","volume":"75","author":"CG Derington","year":"2020","unstructured":"Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, et al. Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005-2016. Hypertension. 2020;75:973\u201381.","journal-title":"Hypertension"},{"key":"1158_CR14","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and control of hypertension: JACC health promotion series. J Am Coll Cardiol. 2018;72:1278\u201393.","journal-title":"J Am Coll Cardiol"},{"key":"1158_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.005624","volume":"12","author":"BK Bellows","year":"2019","unstructured":"Bellows BK, Ruiz-Negron N, Bibbins-Domingo K, King JB, Pletcher MJ, Moran AE, et al. Clinic-based strategies to reach United States Million Hearts 2022 blood pressure control goals. Circ Cardiovasc Qual Outcomes. 2019;12:e005624.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1158_CR16","doi-asserted-by":"publisher","first-page":"e004188","DOI":"10.1161\/JAHA.116.004188","volume":"5","author":"L Mu","year":"2016","unstructured":"Mu L, Mukamal KJ. Treatment intensification for hypertension in US ambulatory medical care. J Am Heart Assoc. 2016;5:e004188.","journal-title":"J Am Heart Assoc"},{"key":"1158_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11906-020-01109-2","volume":"22","author":"J An","year":"2020","unstructured":"An J, Derington CG, Luong T, Olson KL, King JB, Bress AP, et al. Fixed-dose combination medications for treating hypertension: a review of effectiveness, safety, and challenges. Curr Hypertens Rep. 2020;22:95.","journal-title":"Curr Hypertens Rep"},{"key":"1158_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/HYPERTENSIONAHA.120.15781","volume":"77","author":"G Parati","year":"2021","unstructured":"Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J. Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis. Hypertension. 2021;77:692\u2013705.","journal-title":"Hypertension"},{"key":"1158_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/HYPERTENSIONAHA.108.123455","volume":"53","author":"RD Feldman","year":"2009","unstructured":"Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension. 2009;53:646\u201353.","journal-title":"Hypertension"},{"key":"1158_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/jamacardio.2022.0471","volume":"7","author":"SR Gnanenthiran","year":"2022","unstructured":"Gnanenthiran SR, Wang N, Di Tanna GL, Salam A, Webster R, de Silva HA, et al. Association of low-dose triple combination therapy vs usual care with time at target blood pressure: a secondary analysis of the TRIUMPH randomized clinical trial. JAMA Cardiol. 2022;7:645\u201350.","journal-title":"JAMA Cardiol"},{"key":"1158_CR21","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1097\/HJH.0000000000002096","volume":"37","author":"A Salam","year":"2019","unstructured":"Salam A, Kanukula R, Atkins E, Wang X, Islam S, Kishore SP, et al. Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019;37:1768\u201374.","journal-title":"J Hypertens"},{"key":"1158_CR22","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.118.11308","volume":"72","author":"F Rea","year":"2018","unstructured":"Rea F, Corrao G, Merlino L, Mancia G. Initial antihypertensive treatment strategies and therapeutic inertia. Hypertension. 2018;72:846\u201353.","journal-title":"Hypertension"},{"key":"1158_CR23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jama.2018.10359","volume":"320","author":"R Webster","year":"2018","unstructured":"Webster R, Salam A, de Silva HA, Selak V, Stepien S, Rajapakse S, et al. Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka: a randomized clinical trial. JAMA. 2018;320:566\u201379.","journal-title":"JAMA"},{"key":"1158_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102091","volume":"4","author":"D Zhang","year":"2025","unstructured":"Zhang D, Lee JS, Therrien NL, Pollack LM, Jackson SL, Dong X, et al. Association Between fixed-dose combination use and medication adherence, health care utilization, and costs among medicaid beneficiaries. JACC Adv. 2025;4:102091.","journal-title":"JACC Adv"},{"key":"1158_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41371-020-0340-6","volume":"34","author":"CG Derington","year":"2020","unstructured":"Derington CG, Cohen JB, Bress AP. Restoring the upward trend in blood pressure control rates in the United States: a focus on fixed-dose combinations. J Hum Hypertens. 2020;34:617\u201323.","journal-title":"J Hum Hypertens"},{"key":"1158_CR26","doi-asserted-by":"crossref","unstructured":"King JB, An J, Bellows BK, Cohen JB, Commodore-Mensah Y, Ghazi L, et al. Single-Pill combination therapy for the management of hypertension: a scientific statement from the American Heart Association. Hypertension. 2025.","DOI":"10.1161\/HYP.0000000000000258"},{"key":"1158_CR27","unstructured":"Keisler-Starkey K, Bunch LN Health insurance coverage in the United States: 2021. Washington, DC: US Government Publishing Office; 2022. https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2022\/demo\/p60-278.pdf.Accessed January 9, 2026."},{"key":"1158_CR28","unstructured":"US Centers for Medicare & Medicaid Services. State Medicaid and CHIP applications, eligibility determinations, and enrollment data. 2025. https:\/\/data.medicaid.gov\/dataset\/6165f45b-ca93-5bb5-9d06-db29c692a360\/data?conditions[0][property]=report_date&conditions[0][value]=2022-12-01&conditions[0][operator]=%3D&conditions[1][property]=preliminary_updated&conditions[1][value]=U&conditions[1][operator]=%3D. Accessed January 9, 2026."},{"key":"1158_CR29","unstructured":"KFF. Medicaid coverage rates for the nonelderly by race\/ethnicity 2020. https:\/\/www.kff.org\/medicaid\/state-indicator\/nonelderly-medicaid-rate-by-raceethnicity\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D#notes. Accessed January 9, 2026."},{"key":"1158_CR30","unstructured":"Mitchell A Medicaid Primer. Library of Congress. Washington, DC: Congressional Research Service; 2025. https:\/\/www.congress.gov\/crs-product\/IF10322. Accessed March 27, 2026."},{"key":"1158_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.18553\/jmcp.2017.23.8.893","volume":"23","author":"Y Park","year":"2017","unstructured":"Park Y, Raza S, George A, Agrawal R, Ko J. The effect of formulary restrictions on patient and payer outcomes: a systematic literature review. J Managed Care Specialty Pharm. Washington, DC ; 2017;23:893\u2013901.","journal-title":"J Managed Care Specialty Pharm"},{"key":"1158_CR32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jacep.2020.04.022","volume":"6","author":"SP Sharma","year":"2020","unstructured":"Sharma SP, Russo A, Deering T, Fisher J, Lakkireddy D. Prior authorization. Probl solutions JACC Clin Electrophysiol. 2020;6:747\u201350.","journal-title":"Probl solutions JACC Clin Electrophysiol"},{"key":"1158_CR33","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.clinthera.2012.04.003","volume":"34","author":"F Zeng","year":"2012","unstructured":"Zeng F, Park J, Plauschinat CA, Patel BV. Failure to intensify hypertension therapy after rejected aliskiren claims. Clin Ther. 2012;34:1122\u201331.","journal-title":"Clin Ther"},{"key":"1158_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.15585\/mmwr.mm6906a2","volume":"69","author":"A DiGiulio","year":"2020","unstructured":"DiGiulio A, Jump Z, Babb S, Schecter A, Williams KS, Yembra D, et al. State Medicaid coverage for tobacco cessation treatments and barriers to accessing treatments - United States, 2008-2018. MMWR Morb Mortal Wkly Rep. 2020;69:155\u201360.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1158_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.15585\/mmwr.mm7314a2","volume":"73","author":"A DiGiulio","year":"2024","unstructured":"DiGiulio A, Tynan MA, Schecter A, Williams KS, VanFrank B. State Medicaid coverage for tobacco cessation treatments and barriers to accessing treatments - United States, 2018-2022. MMWR Morb Mortal Wkly Rep. 2024;73:301\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1158_CR36","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1016\/j.jacc.2022.04.031","volume":"79","author":"KF Faridi","year":"2022","unstructured":"Faridi KF, Dayoub EJ, Ross JS, Dhruva SS, Ahmad T, Desai NR. Medicare Coverage and out-of-pocket costs of quadruple drug therapy for heart failure. J Am Coll Cardiol. 2022;79:2516\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"1158_CR37","doi-asserted-by":"publisher","first-page":"E110","DOI":"10.5888\/pcd15.180116","volume":"15","author":"K Pruitt","year":"2018","unstructured":"Pruitt K, Yu A, Kaplan BM, Hsu J, Collins P. Medicaid coverage of guidelines-based asthma care across 50 states, the District of Columbia, and Puerto Rico, 2016-2017. Prev Chronic Dis. 2018;15:E110.","journal-title":"Prev Chronic Dis"},{"key":"1158_CR38","doi-asserted-by":"publisher","first-page":"e250695","DOI":"10.1001\/jamanetworkopen.2025.0695","volume":"8","author":"MT Stewart","year":"2025","unstructured":"Stewart MT, Feltus SR, Andrews CM, Acevedo A, Thomas CP, Bratberg J, et al. Alcohol use disorder medication coverage and utilization management in Medicaid managed care plans. JAMA Netw Open. 2025;8:e250695.","journal-title":"JAMA Netw Open"},{"key":"1158_CR39","unstructured":"Centers for Disease Control and Prevention. Fixed-dose combination antihypertensive medications coverage by state Medicaid and Medicaid managed care organizations. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2022. https:\/\/millionhearts.hhs.gov\/files\/FDC-Analysis-50States-DC-508.pdf."},{"key":"1158_CR40","first-page":"461","volume":"31","author":"K Callaway Kim","year":"2025","unstructured":"Callaway Kim K, Roberts ET, Donohue JM, Good CB, Sabik LM, Devine JW, et al. Changes in blood pressure, medication adherence, and cardiovascular-related health care use associated with the 2018 angiotensin receptor blocker recalls and drug shortages among patients with hypertension. J Manag Care Spec Pharm. 2025;31:461\u2013471.","journal-title":"J Manag Care Spec Pharm"},{"key":"1158_CR41","first-page":"1327","volume":"2011","author":"MJ Stephens","year":"2011","unstructured":"Stephens MJ, Finnell JT, Simonaitis L, Overhage JM. Variability in drug formularies and implications in decision support. AMIA Annu Symp Proc. 2011;2011:1327\u201336.","journal-title":"AMIA Annu Symp Proc"},{"key":"1158_CR42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3122\/jabfm.17.6.401","volume":"17","author":"WH Shrank","year":"2004","unstructured":"Shrank WH, Ettner SL, Glassman P, Asch SM. A bitter pill: formulary variability and the challenge to prescribing physicians. J Am Board Fam Pract. 2004;17:401\u20137.","journal-title":"J Am Board Fam Pract"},{"key":"1158_CR43","doi-asserted-by":"publisher","first-page":"e0159366","DOI":"10.1371\/journal.pone.0159366","volume":"11","author":"M Ritchey","year":"2016","unstructured":"Ritchey M, Tsipas S, Loustalot F, Wozniak G. Use of pharmacy sales data to assess changes in prescription- and payment-related factors that promote adherence to medications commonly used to treat hypertension, 2009 and 2014. PLoS One. 2016;11:e0159366.","journal-title":"PLoS One"},{"key":"1158_CR44","doi-asserted-by":"publisher","first-page":"E112","DOI":"10.5888\/pcd17.190440","volume":"17","author":"PK Yang","year":"2020","unstructured":"Yang PK, Ritchey MD, Tsipas S, Loustalot F, Wozniak GD. State and regional variation in prescription- and payment-related promoters of adherence to blood pressure medication. Prev Chronic Dis. 2020;17:E112.","journal-title":"Prev Chronic Dis"},{"key":"1158_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028573","volume":"12","author":"CG Derington","year":"2023","unstructured":"Derington CG, Bress AP, Herrick JS, Jacobs JA, Zheutlin AR, Berchie RO, et al. Antihypertensive medication regimens used by US adults with hypertension and the potential for fixed-dose combination products: The National Health and Nutrition Examination Surveys 2015\u20132020. J Am Heart Assoc. 2023;12:e028573.","journal-title":"J Am Heart Assoc"},{"key":"1158_CR46","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1161\/HYPERTENSIONAHA.123.21132","volume":"80","author":"JB King","year":"2023","unstructured":"King JB, Derington CG, Herrick JS, Jacobs JA, Zheutlin AR, Conroy MB, et al. Single-pill combination product availability of the antihypertensive regimens used for intensive systolic blood pressure treatment in the systolic blood pressure intervention trial. Hypertension. 2023;80:1749\u201358.","journal-title":"Hypertension"},{"key":"1158_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ahj.2021.10.184","volume":"248","author":"AR Zheutlin","year":"2022","unstructured":"Zheutlin AR, Derington CG, King JB, Berchie RO, Herrick JS, Dixon DL, et al. Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race\/ethnicity, National Health and Nutrition Examination Survey 2013-2018. Am Heart J. 2022;248:150\u20139.","journal-title":"Am Heart J"},{"key":"1158_CR48","doi-asserted-by":"publisher","first-page":"e235231","DOI":"10.1001\/jamahealthforum.2023.5231","volume":"5","author":"D Zhang","year":"2024","unstructured":"Zhang D, Lee JS, Pollack LM, Dong X, Taliano JM, Rajan A, et al. Association of economic policies With hypertension management and control: a systematic review. JAMA Health Forum. 2024;5:e235231.","journal-title":"JAMA Health Forum"},{"key":"1158_CR49","doi-asserted-by":"crossref","unstructured":"Kim NH, Look KA The effect of reduced drug copayments on adherence to oral diabetes medications among childless adults in Wisconsin Medicaid. J Manag Care Spec Pharm. 2019;25:1432-41.","DOI":"10.18553\/jmcp.2019.25.12.1432"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01158-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01158-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01158-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:05:46Z","timestamp":1780679146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01158-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":49,"alternative-id":["1158"],"URL":"https:\/\/doi.org\/10.1038\/s41371-026-01158-1","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No ethical approval required as analysis did not involve human participants or their data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}